Comparative in vivo toxicity, organ biodistribution and immune response of pristine, carboxylated and PEGylated few-layer graphene sheets in Swiss albino mice: A three month study

We present a comprehensive 3 month report on the acute and chronic toxicity of intravenously administered (20 mg kg−1) few-layer graphene (FLG) and, its carboxylated (FLG-COOH) and PEGylated (FLG-PEG) derivatives in Swiss albino mice. Whole-animal in vivo tracking studies revealed that irrespective of surface modifications, graphene predominantly accumulated in lungs over a period of 24 h. Histological assessment and ex vivo confocal Raman spectral mapping revealed highest uptake and retention in lung tissue, followed by spleen, liver and kidney, with no accumulation in brain, heart or testis. FLG and FLG-COOH accumulated within organs induced significant cellular and structural damages to lungs, liver, spleen, and kidney, ranging from mild congestion to necrosis, fibrosis and glomerular filtration dysfunction, without appreciable clearance. Serum biochemistry analysis revealed that both FLG and FLG-COOH induced elevated levels of hepatic and renal injury markers. Quantitative RT-PCR studies conducted on 23 critical inflammation and immune response markers showed major alterations in gene expression profile by FLG, FLG-COOH and FLG-PEG treated animals. FLG-PEG in spite of its persistance within liver and spleen tissue for 3 months, did not induce any noticeable toxicity or organ damage, and displayed significant changes in Raman spectra, indicative of their biodegradation potential.

[1]  Gil Gonçalves,et al.  The effects of graphene oxide nanosheets localized on F-actin filaments on cell-cycle alterations. , 2013, Biomaterials.

[2]  Jie Meng,et al.  Immune responses of BALB/c mice to subcutaneously injected multi-walled carbon nanotubes , 2011, Nanotoxicology.

[3]  Kai Yang,et al.  In vitro and in vivo behaviors of dextran functionalized graphene , 2011 .

[4]  A. Olszyna,et al.  Recent advances in graphene family materials toxicity investigations , 2012, Journal of Nanoparticle Research.

[5]  Yanli Chang,et al.  Effect of size and dose on the biodistribution of graphene oxide in mice. , 2012, Nanomedicine.

[6]  Craig A. Poland,et al.  Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. , 2008, Nature nanotechnology.

[7]  C. Rao,et al.  A study of graphenes prepared by different methods: characterization, properties and solubilization , 2008 .

[8]  Kai Yang,et al.  In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice. , 2011, ACS nano.

[9]  Deepthy Menon,et al.  Differential nano-bio interactions and toxicity effects of pristine versus functionalized graphene. , 2011, Nanoscale.

[10]  H. Dai,et al.  Carbon nanotubes in biology and medicine: In vitro and in vivo detection, imaging and drug delivery , 2009, Nano research.

[11]  Kostas Kostarelos,et al.  Graphene devices for life. , 2014, Nature nanotechnology.

[12]  Debabrata Dash,et al.  Amine-modified graphene: thrombo-protective safer alternative to graphene oxide for biomedical applications. , 2012, ACS nano.

[13]  Kai Yang,et al.  In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene. , 2012, ACS nano.

[14]  Chunhai Fan,et al.  Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration , 2011 .

[15]  Vincenzo Palermo,et al.  Dispersibility-Dependent Biodegradation of Graphene Oxide by Myeloperoxidase. , 2015, Small.

[16]  Vasileios Koutsos,et al.  Minimal oxidation and inflammogenicity of pristine graphene with residence in the lung , 2014, Nanotoxicology.

[17]  Jiali Zhang,et al.  Biocompatibility of Graphene Oxide , 2010, Nanoscale research letters.

[18]  B. Hong,et al.  Prospects and Challenges of Graphene in Biomedical Applications , 2013, Advanced materials.

[19]  Junko Nakanishi,et al.  Reproductive and developmental toxicity studies of manufactured nanomaterials. , 2010, Reproductive toxicology.

[20]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[21]  M. Kitto,et al.  Evaluation of sample pretreatment methods for multiwalled and single-walled carbon nanotubes for the determination of metal impurities by ICPMS, ICPOES, and instrument neutron activation analysis , 2010 .

[22]  C. Rao,et al.  Simple Method of Preparing Graphene Flakes by an Arc-Discharge Method , 2009 .

[23]  Roberto Car,et al.  Functionalized single graphene sheets derived from splitting graphite oxide. , 2006, The journal of physical chemistry. B.

[24]  Marco Orecchioni,et al.  Graphene as Cancer Theranostic Tool: Progress and Future Challenges , 2015, Theranostics.

[25]  Deepthy Menon,et al.  Hemocompatibility and macrophage response of pristine and functionalized graphene. , 2012, Small.

[26]  Kai Yang,et al.  In vivo biodistribution and toxicology of functionalized nano-graphene oxide in mice after oral and intraperitoneal administration. , 2013, Biomaterials.

[27]  Hao Hong,et al.  Graphene: a versatile nanoplatform for biomedical applications. , 2012, Nanoscale.

[28]  S. Shrivastava,et al.  Thrombus inducing property of atomically thin graphene oxide sheets. , 2011, ACS nano.

[29]  A. Irajizad,et al.  Melatonin as a powerful bio-antioxidant for reduction of graphene oxide , 2011 .

[30]  Filip Braet,et al.  Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review , 2002, Comparative hepatology.

[31]  Abhilash Sasidharan,et al.  Radiofrequency Ablation of Drug‐Resistant Cancer Cells Using Molecularly Targeted Carboxyl‐Functionalized Biodegradable Graphene , 2015, Advanced healthcare materials.

[32]  Bengt Fadeel,et al.  Classification framework for graphene-based materials. , 2014, Angewandte Chemie.

[33]  Kostas Kostarelos,et al.  Tissue distribution and urinary excretion of intravenously administered chemically functionalized graphene oxide sheets† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c5sc00114e , 2015, Chemical science.

[34]  Craig A. Poland,et al.  Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma , 2010, Particle and Fibre Toxicology.

[35]  Marina A Dobrovolskaia,et al.  Nanoparticles and the immune system. , 2010, Endocrinology.

[36]  Abhilash Sasidharan,et al.  Confocal Raman Imaging Study Showing Macrophage Mediated Biodegradation of Graphene In Vivo , 2013, Advanced healthcare materials.

[37]  R. Bone,et al.  Sepsis: a new hypothesis for pathogenesis of the disease process. , 1997, Chest.

[38]  Maurizio Prato,et al.  Safety concerns on graphene and 2D materials: a Flagship perspective , 2015 .

[39]  S. Nair,et al.  Biomedical Applications of Graphene: Opportunities and Challenges , 2012 .

[40]  M. Cesta.  Normal Structure, Function, and Histology of the Spleen , 2006, Toxicologic pathology.

[41]  Feng Zhao,et al.  Low-toxic and safe nanomaterials by surface-chemical design, carbon nanotubes, fullerenes, metallofullerenes, and graphenes. , 2011, Nanoscale.

[42]  Alberto Bianco,et al.  Graphene: safe or toxic? The two faces of the medal. , 2013, Angewandte Chemie.

[43]  M. Prato,et al.  Carbon nanotubes as nanomedicines: from toxicology to pharmacology. , 2006, Advanced drug delivery reviews.

[44]  Qing Huang,et al.  Influence of polyethylene glycol coating on biodistribution and toxicity of nanoscale graphene oxide in mice after intravenous injection , 2014, International journal of nanomedicine.

[45]  X. Qu,et al.  A graphene functionalized electrochemical aptasensor for selective label-free detection of cancer cells. , 2011, Biomaterials.

[46]  Kai Yang,et al.  Surface coating-dependent cytotoxicity and degradation of graphene derivatives: towards the design of non-toxic, degradable nano-graphene. , 2014, Small.

[47]  R. Aitken,et al.  Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[48]  C. Dinarello,et al.  Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. , 1993, JAMA.

[49]  Wolfgang J. Parak,et al.  Back to Basics: Exploiting the Innate Physico‐chemical Characteristics of Nanomaterials for Biomedical Applications , 2014 .

[50]  Chor Yong Tay,et al.  Understanding and exploiting nanoparticles' intimacy with the blood vessel and blood. , 2015, Chemical Society reviews.